Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | RHOA | P61586 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5772028 | 0.83 | TSHR (0.52) | ALDH1A1HSD17B10TSHRMAPTMEN1 | |
| SCHEMBL27438623 | 0.82 | CYP3A4 (0.61) | CYP3A4ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL429498 | 0.81 | CYP3A4 (0.50) | CYP3A4ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL9717642 | 0.79 | CYP3A4 (0.69) | CYP3A4ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL429496 | 0.77 | CYP3A4 (0.56) | CYP3A4ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL9422015 | 0.77 | CYP3A4 (0.67) | CYP3A4ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL28431291 | 0.77 | CYP3A4 (0.67) | CYP3A4ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL302697 | 0.77 | TSHR (0.55) | CYP3A4ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL3969049 | 0.76 | CA12 (0.42) | ALDH1A1HSD17B10TSHRMAPTMEN1 | |
| SCHEMBL11800019 | 0.76 | CYP3A4 (0.65) | CYP3A4ALDH1A1HSD17B10TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2710045-A1 | HALOGEN FREE THERMOSET RESIN SYSTEM FOR LOW DIELECTRIC LOSS AT HIGH FREQUENCY APPLICATIONS | Huntsman Advanced Materials Americas LLC (US) | 2014-03-26 | — | — | EP | disclosed |
| US-20140057086-A1 | Halogen Free Thermoset Resin System for Low Dielectric Loss at High Frequency Applications | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2014-02-27 | — | — | US | disclosed |
| WO-2012158415-A1 | HALOGEN FREE THERMOSET RESIN SYSTEM FOR LOW DIELECTRIC LOSS AT HIGH FREQUENCY APPLICATIONS | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2012-11-22 | — | — | WO | disclosed |
| US-7803298-B2 | Molding material, molded part, and method for manufacturing them | SUMITOMO ELECTRIC FINE POLYMER, INC. (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20090085260-A1 | BIODEGRADABLE MATERIAL AND PROCESS FOR PRODUCING THE SAME | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090030160-A1 | Polylactic Acid Complex and Production Method Thereof | SUMITOMO ELECTRIC FINE POLYMER INC. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-20080213209-A1 | Process for Producing Cross-Linked Material of Polylactic Acid and Cross-Linked Material of Polylactic Acid | SUMITOMO ELECTRIC FINE POLYMER, INC. (JP) | 2008-09-04 | — | — | US | disclosed |
| US-20080036119-A1 | Molding material, molded part, and method for manufacturing them | SUMITOMO ELECTRIC FINE POLYMER, INC. | 2008-02-14 | — | — | US | disclosed |
| US-20060160984-A1 | Biodegradable material and process for producing the same | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090085260-A1 | BIODEGRADABLE MATERIAL AND PROCESS FOR PRODUCING THE SAME | TST, PCMT1, XRCC6 | CYP3A4 1680/4885ALDH1A1 1504/4885HSD17B10 909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.